Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chuanmeng Zhang

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Molecular Diagnosis & Therapy|May 16, 2020
Prognostic Value of L-Type Amino Acid Transporter 1 (LAT1) in Various Cancers: A Meta-AnalysisChuanmeng Zhang, Jie Xu, Shanshan Xue, et al.
Disease Markers|March 22, 2021
Prognostic Value of Peroxiredoxin-1 Expression in Patients with Solid Tumors: a Meta-Analysis of Cohort StudyLianghe Jiao, Jing Wei, Jun Ye, et al.
Disease Markers|February 7, 2022
Increased Sphingosine Kinase 1 Expression Is Associated with Poor Prognosis in Human Solid Tumors: A Meta-AnalysisChuanmeng Zhang, Chenglin Zhou, Jie Xu, et al.
Medicine|June 27, 2022
Prognostic significance of A-kinase interacting protein 1 expression in various cancers: A meta-analysis based on the Chinese populationShanshan Xue, Chuanmeng Zhang, Jie Xu, et al.
Medicine|August 16, 2021
Prognostic value of HHLA2 expression in solid tumors: A meta-analysis based on the Chinese populationChuanmeng Zhang, Jie Xu, Jun Ye, et al.
Medicine|October 8, 2020
Low NDRG2 expression predicts poor prognosis in solid tumors: A meta-analysis of cohort studyAiqin Gu, Jie Xu, Jun Ye, et al.
Scientific Reports|January 6, 2024
Prevalence and influential factors of isolated hepatitis B core antibody positivity in a Chinese adult populationChengwei Wang, Xiaoqin Li, Chuanmeng Zhang, et al.
Frontiers in Microbiology|July 9, 2026
<i>Akkermansia muciniphila</i> in cardiovascular diseases: opportunities and challengesShihao Li, Chuanmeng Zhang, Min Sha, et al.
Frontiers in Immunology|February 10, 2023
Quantitative fluorescence resonance energy transfer-based immunoassay for activated complement C1sJun Ye, Jie Xu, Chuanmeng Zhang, et al.
Frontiers in Oncology|December 19, 2022
Prognostic value of Musashi 2 (MSI2) in cancer patients: A systematic review and meta-analysisLin Jiang, Shanshan Xue, Jie Xu, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Molecular Diagnosis & Therapy|May 16, 2020
Prognostic Value of L-Type Amino Acid Transporter 1 (LAT1) in Various Cancers: A Meta-AnalysisChuanmeng Zhang, Jie Xu, Shanshan Xue, et al.
Disease Markers|March 22, 2021
Prognostic Value of Peroxiredoxin-1 Expression in Patients with Solid Tumors: a Meta-Analysis of Cohort StudyLianghe Jiao, Jing Wei, Jun Ye, et al.
Disease Markers|February 7, 2022
Increased Sphingosine Kinase 1 Expression Is Associated with Poor Prognosis in Human Solid Tumors: A Meta-AnalysisChuanmeng Zhang, Chenglin Zhou, Jie Xu, et al.
Medicine|June 27, 2022
Prognostic significance of A-kinase interacting protein 1 expression in various cancers: A meta-analysis based on the Chinese populationShanshan Xue, Chuanmeng Zhang, Jie Xu, et al.
Medicine|August 16, 2021
Prognostic value of HHLA2 expression in solid tumors: A meta-analysis based on the Chinese populationChuanmeng Zhang, Jie Xu, Jun Ye, et al.
Medicine|October 8, 2020
Low NDRG2 expression predicts poor prognosis in solid tumors: A meta-analysis of cohort studyAiqin Gu, Jie Xu, Jun Ye, et al.
Scientific Reports|January 6, 2024
Prevalence and influential factors of isolated hepatitis B core antibody positivity in a Chinese adult populationChengwei Wang, Xiaoqin Li, Chuanmeng Zhang, et al.
Frontiers in Microbiology|July 9, 2026
<i>Akkermansia muciniphila</i> in cardiovascular diseases: opportunities and challengesShihao Li, Chuanmeng Zhang, Min Sha, et al.
Frontiers in Immunology|February 10, 2023
Quantitative fluorescence resonance energy transfer-based immunoassay for activated complement C1sJun Ye, Jie Xu, Chuanmeng Zhang, et al.
Frontiers in Oncology|December 19, 2022
Prognostic value of Musashi 2 (MSI2) in cancer patients: A systematic review and meta-analysisLin Jiang, Shanshan Xue, Jie Xu, et al.
Pageof 3